Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, operates as a pharmaceutical manufacturing holding investment company in China. The company engages in the research and development, and production of anti-tumor, cardiovascular, cerebrovascular, rheumatism bone pain, tonic and sedative, cold and cough, anti-fungal, gynecology, and other treatment fiel… Read more
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (900904) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2023: 0.050x
Based on the latest financial reports, Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (900904) has a cash flow conversion efficiency ratio of 0.050x as of June 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($118.87 Million) by net assets ($2.36 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Greene County Bancorp Inc
NASDAQ:GCBC
|
0.025x |
|
Verano Holdings Corp
OTCQX:VRNOF
|
0.012x |
|
Hangzhou Tianyuan Pet Products Co. Ltd. A
SHE:301335
|
N/A |
|
APAC Opto Electronics
TWO:4908
|
0.007x |
|
M-tron Industries, Inc.
NYSE MKT:MPTI
|
0.095x |
|
Tederic Machinery Co Ltd
SHG:603289
|
0.020x |
|
Caisse régionale de Crédit Agricole Mutuel Atlantique Vendée
PA:CRAV
|
-0.105x |
|
TROOPS Inc
NASDAQ:TROO
|
-0.081x |
Annual Cash Flow Conversion Efficiency for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (2015–2024)
The table below shows the annual cash flow conversion efficiency of Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B from 2015 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $2.43 Billion | $207.79 Million | 0.086x | -5.06% |
| 2023-12-31 | $2.39 Billion | $215.59 Million | 0.090x | -32.99% |
| 2022-12-31 | $2.37 Billion | $319.23 Million | 0.135x | +74.76% |
| 2021-12-31 | $2.39 Billion | $184.26 Million | 0.077x | +80.90% |
| 2020-12-31 | $2.33 Billion | $99.10 Million | 0.043x | -11.67% |
| 2019-12-31 | $2.66 Billion | $128.28 Million | 0.048x | -15.67% |
| 2018-12-31 | $2.60 Billion | $148.53 Million | 0.057x | +115.90% |
| 2017-12-31 | $2.53 Billion | $66.99 Million | 0.026x | +11200.02% |
| 2016-12-31 | $2.43 Billion | $570.41K | 0.000x | -98.22% |
| 2015-12-31 | $2.29 Billion | $30.12 Million | 0.013x | -- |